Literature DB >> 17535915

Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival.

Xia Liu1, Zhixue Liu, Sung-Wuk Jang, Zhiyong Ma, Kazuya Shinmura, Sumin Kang, Shaozhong Dong, Jing Chen, Kenji Fukasawa, Keqiang Ye.   

Abstract

Nucleophosmin/B23 is a major multifunctional nucleolar phosphoprotein that plays a critical role in ribosome biogenesis and cell proliferation. Arf tumor suppressor binds B23 and enhances its sumoylation. However, the biological effects of this event remain unknown. Here we show that B23 is sumoylated on both Lysine 230 and 263 residues, but the latter is the major one. Mutation of K263, but not K230, into R abolishes its centrosomal and nucleolar residency. Moreover, Rb binds to wild-type B23, but fails to interact with K263R. Sumoylation enhances B23 binding to Rb. Consequently, B23 potently stimulates E2F1-mediated transcriptional activity, which is abolished in B23 K263R. Further, K263R mutation makes B23 vulnerable to caspase-3 cleavage and sensitizes cells to apoptosis. Surprisingly, K230R mutant strongly binds to phosphatidylinositol-3,4,5-trisphosphate and suppresses DNA fragmentation. Thus, B23 sumoylation regulates its subcellular localization, cell proliferation, and survival activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535915      PMCID: PMC1887583          DOI: 10.1073/pnas.0701806104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

Authors:  Koji Itahana; Krishna P Bhat; Aiwen Jin; Yoko Itahana; David Hawke; Ryuji Kobayashi; Yanping Zhang
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

Review 2.  Variations on a theme: the alternate translocations in APL.

Authors:  R L Redner
Journal:  Leukemia       Date:  2002-10       Impact factor: 11.528

3.  Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression.

Authors:  Ming H Wu; Jei H Chang; Benjamin Y M Yung
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

4.  NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

Authors:  Roberto Chiarle; Jerald Z Gong; Ilaria Guasparri; Anna Pesci; Jonjing Cai; Jian Liu; William J Simmons; Girish Dhall; Jennifer Howes; Roberto Piva; Giorgio Inghirami
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

5.  Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.

Authors:  P Tarapore; H F Horn; Y Tokuyama; K Fukasawa
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

6.  Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.

Authors:  Masaharu Takemura; Fumiharu Ohoka; Marinela Perpelescu; Masanori Ogawa; Hidenobu Matsushita; Tomoyuki Takaba; Tetsu Akiyama; Hayato Umekawa; Yukio Furuichi; Peter R Cook; Shonen Yoshida
Journal:  Exp Cell Res       Date:  2002-06-10       Impact factor: 3.905

7.  Nucleophosmin sets a threshold for p53 response to UV radiation.

Authors:  Dony A Maiguel; Leslie Jones; Devulapalli Chakravarty; Chonglin Yang; France Carrier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.

Authors:  June Li; Xiaoling Zhang; Daniel P Sejas; Grover C Bagby; Qishen Pang
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

9.  MDM2-ARF complex regulates p53 sumoylation.

Authors:  Lihong Chen; Jiandong Chen
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

10.  Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.

Authors:  Lili Zhao; Tina Samuels; Sarah Winckler; Chandrashekhar Korgaonkar; Van Tompkins; Mary C Horne; Dawn E Quelle
Journal:  Mol Cancer Res       Date:  2003-01       Impact factor: 5.852

View more
  35 in total

1.  HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype.

Authors:  Simona Fiorentini; Elena Riboldi; Fabio Facchetti; Manuela Avolio; Marco Fabbri; Giorgio Tosti; Pablo D Becker; Carlos A Guzman; Silvano Sozzani; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-29       Impact factor: 11.205

Review 2.  Nucleolar targeting: the hub of the matter.

Authors:  Edward Emmott; Julian A Hiscox
Journal:  EMBO Rep       Date:  2009-02-20       Impact factor: 8.807

3.  Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites.

Authors:  Henri A Blomster; Ville Hietakangas; Jianmin Wu; Petri Kouvonen; Sampsa Hautaniemi; Lea Sistonen
Journal:  Mol Cell Proteomics       Date:  2009-02-24       Impact factor: 5.911

Review 4.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

Review 5.  Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.

Authors:  Luca Federici; Brunangelo Falini
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

Review 6.  Regulation of nucleolus assembly by non-coding RNA polymerase II transcripts.

Authors:  Maïwen Caudron-Herger; Teresa Pankert; Karsten Rippe
Journal:  Nucleus       Date:  2016-05-03       Impact factor: 4.197

7.  An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer.

Authors:  Piia-Riitta Karhemo; Antti Rivinoja; Johan Lundin; Maija Hyvönen; Anastasiya Chernenko; Johanna Lammi; Harri Sihto; Mikael Lundin; Päivi Heikkilä; Heikki Joensuu; Petri Bono; Pirjo Laakkonen
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

8.  Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon Bonegio; Andrea Havasi; Katarina Illanes; John H Schwartz; Steven C Borkan
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

9.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

10.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.